Abcuro
Abcuro develops immunotherapies to treat autoimmunity and cancer.
Drug Discovery
📍 Newton, MA
Founded 2015
Current Valuation
$700M
as of 2025-Q1
PRIVATE
Abcuro develops immunotherapies to treat autoimmunity and cancer.
Company Profile
Last Round
Series C — $200M (Feb 2025)
Fundraising Status
Series C · $200M · 1y 4mo ago
privateTotal raised $407M
Latest Funding Round
| Round | Amount | Date | Lead Investor | Post-Money |
|---|
| Series C | $200M | Feb 2025 | — | $700M |
BiotechnologyHealth CareMedical
Private-company numbers are not real-time. Reflects publicly disclosed valuations from press releases, news reports, and tender offers as of 2025-Q1. Refreshed quarterly.